Novara Mark David

Insider profile

Novara Mark David's trades of Tandem Diabetes Care Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-05-19 2026-05-19 PrS Proposed sale
24,503
329.71
US$654,583
24,503 329.71 US$654,583
2026-03-18 2026-03-17 PlS Planned sale
58,772 -24.8%
481.09
US$1,677,001
58,772 -24.8% 481.09 US$1,677,001
2026-03-17 2026-03-17 PrS Proposed sale
59,747
477.99
US$3,501,174
59,747 477.99 US$3,501,174
2026-03-09 2026-03-05 PlS Planned sale
2 -0.0%
22.81
US$46
2 -0.0% 22.81 US$46
2026-03-05 2026-03-05 PrS Proposed sale
2
23.41
US$47
2 23.41 US$47
2024-11-19 2024-11-15 PP Planned purchase
532 +inf%
23.24
US$12,364
532 +inf% 23.24 US$12,364